Invest Precision Medicine Conference June 9-11, which will be conducted online, will explore a wide range of topics from advancing breakthrough treatments for rare disease and cancer, genetic testing, health equity, pediatric innovation and more.
But like all events at MedCity, startups will also be in the limelight. Startup Pitch Competition Pitch Perfect has a Health IT track scheduled for June 9th from 3:30-5pm ET and a Life Science track scheduled for June 10th from 3:30pm-5pm ET. Earlier this week we Life Sciences Track Companies Previewed. Take a look at the companies in the Health IT track:
bioexplore Developed a proprietary biomedical data platform and product suite of tools and algorithms for clinical responder analysis, drug combination and indication elaboration.
Intellihealth is a medical technology company that is changing the perception and treatment of obesity. Built on 30 years of clinical experience, our data-driven technology allows us to tackle the obesity epidemic by equipping any medical provider with a comprehensive, turnkey solution to treat obese patients remotely or in person. is. Our software integrates with EHR to improve outcomes and drive cost savings by personalizing and customizing the diagnosis, prescriptive process and comprehensive therapy planning to treat obesity as a disease. Providers benefit from new revenue through more effective patient interactions and optimized billing, while payers and self-insured organizations achieve significant healthcare-related cost savings through a healthier workforce.
vocal health is an AI healthtech company that is a leader in the development of vocal biomarkers – where health information is derived from the analysis of people’s voice recordings – to detect, detect, monitor and predict health symptoms, conditions and diseases. Vocalis Health is currently focused on screening users for Covid-19 and monitoring patients with chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF) and Pulmonary Hypertension.
phenobiome is on a mission to become the gold standard for developing microbiome-based solutions in the human, animal and agritech markets from assay development to therapeutics.
AIQ Solutions has developed a revolutionary software technology that will transform the way physicians manage complex diseases such as metastatic cancer and neurological disorders. The cloud-based platform provides unique, early intelligence to predict both treatment effectiveness and toxicity risk from longitudinal imaging data. AIQ’s technology does not diagnose disease; Rather it enables the clinical team to make real-time, patient-specific adjustments to therapy, which helps improve outcomes while reducing costs to the healthcare system. AIQ has manufactured and validated its product, won FDA approval, and is on track to recognize $1 million in revenue in 2021. The company is actively seeking a $10 million Series A-1 to support commercialization activities.
Photo: Adam Taylor, Getty Images